Consequências da hiperhomocisteinemia sobre a resposta à endotelina-1 e fenilefrina em corpo cavernoso de ratos

Abstract

2), suggesting possible loss of the enzyme superoxide dismutase (SOD). The participation of metabolites derived from eNOS, nNOS and iNOS, that modulate negatively PhE-induced contraction appear to be important in this response. In HHcy, these metabolites, derived primary from iNOS, are damaged, possibly by reducing the activity of NOS, the process of decoupling and/or reduced bioavailability of NO by interaction with reactive oxidative species (ROS) to form peroxynitrite. The expression of nitrotyrosine, inidicador the presence of peroxynitrite, was not altered in HHcy rat corpus cavernosum. Plasma levels of nitrate showed reduced levels of NO in HHcy rats, being suggestive of reduced bioavailability. The HHcy did not alter the expression of mRNA for eNOS, iNOS and nNOS in rat corpus cavernosum. The metabolites of the enzyme cyclooxygenase-1 (COX-1) and COX-2 participate negatively modulating the contraction of PhE and HHcy does not seem to change this modulation. In conclusion, intermediate HHcy, by its ability to increase basal levels of O 2-, may affect the vasoactive function, contraction and relaxation of ET-1 peptide, as well as increase the contraction induced by PhE due to decrease of H 2 O 2 and reduced of the metabolites derived from iNOS in rat corpus cavernosum.